phenanthrene

Small moleculeexperimental

Phenanthrene is a polycyclic aromatic hydrocarbon (PAH) with formula C14H10, consisting of three fused benzene rings. It is a colorless, crystal-like solid, but can also appear yellow. Phenanthrene is used to make dyes, plastics, pesticides, explosives, and drugs. It has also been used to make bile acids, cholesterol and steroids. — Wikipedia

Clinical trial activity

2 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2019 (NCT03631667)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Loading structure…

SMILES

c1ccc2c(c1)ccc1ccccc12
Mol. weight
178.23 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07134426N/ADec 1, 2025University of Minnesota
NCT03631667Early Phase 1 (Phase 1)Nov 1, 2019Lawrence Livermore National Laboratory, National Institute of Environmental Health Sciences (NIEHS), Oregon State University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Lawrence Livermore National LaboratoryGovernment1012019
National Institute of Environmental Health Sciences (NIEHS)Government1012019
Oregon State UniversityAcademic/Hospital1112019
University of MinnesotaAcademic/Hospital1112025
4 organizations
Page 1 / 1